For many patients, especially those with type 2 diabetes, obesity, or weight-related health concerns, these medications can be powerful tools when prescribed and monitored appropriately
Some individuals experience reflux during dose escalation phases, while others notice symptoms level off as their bodies adapt over 4-8 weeks
In the Phase 2 clinical trial published in The New England Journal of Medicine in 2023, gastrointestinal side effects affected the majority of participants, with nausea, vomiting, diarrhea, and constipation being the most frequent complaints
You can't be too careful
At Envizion Medical, we combine this powerful medication with in-office support to help you lose weight safely, effectively, and with confidence
Islet alpha cells and glucagoncritical regulators of energy homeostasis